Learn more

BUNDESREPUBLIK DEUTSCHLAND LET

Overview
  • Total Patents
    42
About

BUNDESREPUBLIK DEUTSCHLAND LET has a total of 42 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Germany. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are CYNATA THERAPEUTICS LTD, PETTE HEINRICH INST and GAIA BIOMEDICINE INC.

Patent filings per year

Chart showing BUNDESREPUBLIK DEUTSCHLAND LETs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cichutek Klaus 25
#2 Kroczek Richard 9
#3 Engelstaedter Martin 6
#4 Merget-Millitzer Heike 5
#5 Stitz Joern 3
#6 Engelstadter Martin 3
#7 Stitz Jorn 2
#8 Schweizer Matthias 2
#9 Layer Liliana 2
#10 Schumann Gerald 2

Latest patents

Publication Filing date Title
WO2009000539A1 Modulation of production of retroviruses by apobec4
EP2062592A1 System for delivery into a XCR1 positive cell and uses thereof
EP2055784A1 Controlled activation of non-LTR retrotransposons in mammals
EP1923468A1 Lentiviral vectors for gene transfer in quiescent (G0) cells
EP1975239A1 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening
WO2005103086A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
DE10111433A1 Replication-competent molecular clones of porcine endogenous retrovirus class A and class B, derived from porcine and human cells
DE19946142A1 Cell-targeting vector selective for T lymphocytes, useful in gene therapy of e.g. acquired immune deficiency syndrome, encodes a single-chain variable antibody fragment
DE19917838A1 Composition for treating prion or other neurodegenerative diseases, comprises a peptide that inhibits unfolding of the prion to its pathological isoform
DE19909769A1 SIVagm-derived lentiviral vectors, processes for their preparation and their use for gene transfer in mammalian cells
EP1017723A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
DE19821060A1 T cell co-stimulating polypeptide, monoclonal antibodies, and the production and use thereof
DE19808438A1 Retroviral vectors, processes for their preparation and their use for gene transfer into CD4-positive cells
WO9838325A2 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
DE19752854A1 Cell-specific retroviral vectors with antibody domains and methods for their production for selective gene transfer
DE19752855A1 Retroviral pseudotype vectors with modified surface envelope proteins and packaging cells for their production for selective gene transfer